نتایج جستجو برای: dlbcl lymphoma

تعداد نتایج: 102737  

Journal: :Blood 2008
Lindsay M Morton Sophia S Wang Wendy Cozen Martha S Linet Nilanjan Chatterjee Scott Davis Richard K Severson Joanne S Colt Mohammad A Vasef Nathaniel Rothman Aaron Blair Leslie Bernstein Amanda J Cross Anneclaire J De Roos Eric A Engels David W Hein Deirdre A Hill Linda E Kelemen Unhee Lim Charles F Lynch Maryjean Schenk Sholom Wacholder Mary H Ward Shelia Hoar Zahm Stephen J Chanock James R Cerhan Patricia Hartge

Understanding patterns of etiologic commonality and heterogeneity for non-Hodgkin lymphomas may illuminate lymphomagenesis. We present the first systematic comparison of risks by lymphoma subtype for a broad range of putative risk factors in a population-based case-control study, including diffuse large B-cell (DLBCL; N = 416), follicular (N = 318), and marginal zone lymphomas (N = 106), and ch...

Journal: :Blood 2012
Mary Pulvino Yue Liang David Oleksyn Michael DeRan Elise Van Pelt Joel Shapiro Ignacio Sanz Luojing Chen Jiyong Zhao

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, remains a partially curable disease. Genetic alterations affecting components of NF-κB signaling pathways occur frequently in DLBCL. Almost all activated B cell-like (ABC) DLBCL, which is the least curable group among the 3 major subtypes of this malignancy, and a substantial fraction of germinal center B cell-...

2017
Wen Zheng YuQin Song Yan Xie NingJing Lin MeiFeng Tu WeiPing Liu LingYan Ping ZhiTao Ying Chen Zhang LiJuan Deng XiaoPei Wang YouYong Lu Jun Zhu

Background: Diagnosis of central nervous system (CNS) lymphoma remains a challenge. This study aimed to identify cerebrospinal fluid (CSF) proteins that distinguish patients with and without CNS lymphoma. Methods: We used one-dimensional SDS-polyacrylamide gel electrophoresis coupled with liquid chromatography- electrospray ionization-quadrupole-time of flight-mass spectrometry (LC-ESI-Q-TOF MS...

Journal: :Blood 2011
Vanessa J Craig Sergio B Cogliatti Jochen Imig Christoph Renner Stefan Neuenschwander Hubert Rehrauer Ralph Schlapbach Stephan Dirnhofer Alexander Tzankov Anne Müller

Gastric marginal zone B-cell lymphoma of MALT type (MALT lymphoma) arises in the context of chronic inflammation induced by the bacterial pathogen Helicobacter pylori. Although generally considered an indolent disease, MALT lymphoma may transform to gastric diffuse large B-cell lymphoma (gDLBCL) through mechanisms that remain poorly understood. By comparing microRNA expression profiles of gastr...

2017
Miodrag Vrbic Ivan Petkovic Svetislav Vrbic Maja Jovanovic Aleksandar Rankovic Lidija Popovic-Dragonjic Marina Djordjevic-Spasic

INTRODUCTION HIV-infected patients are affected significantly more frequently by all types of lymphoma, with diffuse large B-cell lymphoma (DLBCL) as the most prevalent histological type. Since the introduction of combination antiretroviral therapy (cART) morbidity and mortality of DLBCL has been markedly reduced, which is primarily interpreted as a result of the drug-mediated immune reconstitu...

Journal: :Biochemical Society transactions 2007
A Melnick

DLBCL (diffuse large B-cell lymphoma) is the most common subtype of non-Hodgkin's lymphoma. Current therapy for patients includes chemotherapy and monoclonal antibodies. Although oncogene-targeted therapy is dramatically successful for patients with certain kinds of leukaemias, there are no such agents yet for DLBCL. One reason for this is that several key oncogenes involved in DLBCL pathogenes...

2012
Mary Pulvino Yue Liang David Oleksyn Michael DeRan Elise Van Pelt Joel Shapiro Ignacio Sanz Luojing Chen Jiyong Zhao

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, remains a partially curable disease. Genetic alterations affecting components of NFB signaling pathways occur frequently in DLBCL. Almost all activated B cell–like (ABC) DLBCL, which is the least curable group among the 3 major subtypes of this malignancy, and a substantial fraction of germinal center B cell–li...

2013
Manikhandan A. V. Mudaliar Ross D. Haggart Gino Miele Grant Sellar Karen A. L. Tan John R. Goodlad Elspeth Milne David M. Vail Ilene Kurzman Daniel Crowther David J. Argyle

We present the first comparison of global transcriptional changes in canine and human diffuse large B-cell lymphoma (DLBCL), with particular reference to the nuclear factor-kappa B (NF-κB) pathway. Microarray data generated from canine DLBCL and normal lymph nodes were used for differential expression, co-expression and pathway analyses, and compared with analysis of microarray data from human ...

Journal: :International journal of clinical and experimental pathology 2013
Kei-Ji Sugimoto Hidenori Imai Asami Shimada Mutsumi Wakabayashi Yasunobu Sekiguchi Noriko Nakamura Tomohiro Sawada Hiroshi Izumi Yasunori Ota Norio Komatsu Masaaki Noguchi

The patient was a 72-year-old female with the chief complaint of abdominal fullness. A giant primary myoma of the uterine cervix was suspected, and total hysterectomy was performed. Based on a postoperative histopathological examination of the tumor a diagnosis of diffuse large B-cell lymphoma (DLBCL) was made in the uterus and a mass in the greater omentum was diagnosed as a marginal zone B-ce...

Journal: :Blood 2011
Shuhua Cheng Greg Coffey X Hannah Zhang Rita Shaknovich Zibo Song Pin Lu Anjali Pandey Ari M Melnick Uma Sinha Y Lynn Wang

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma, and the role of SYK in its pathogenesis is not completely understood. Using tissue microarray, we demonstrated for the first time that SYK protein is activated in 27 of 61 (44%) primary human DLBCL tissues. Among DLBCL cell lines, 7 were sensitive and 3 were resistant to a highly specific SYK inhibitor, PRT06...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید